Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsunori Murata

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Health Economics and Outcomes Research|July 21, 2020
Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in JapanTatsunori Murata, Korenori Arai, Kosuke Kashiwagi, et al.
Value in Health Regional Issues|December 19, 2021
Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment With Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in JapanTomohiro Hirose, Isao Kawaguchi, Tatsunori Murata, et al.
Advances in Therapy|September 13, 2023
Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled TrialsSeiji Fukumoto, Tatsunori Murata, Yutaka Osuga, et al.
The Journal of Dermatology|March 4, 2017
Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data CenterMariko Honda, Tatsunori Murata, Nozomi Ebata, et al.
Journal of Medical Economics|April 3, 2023
Evaluating process utilities for the treatment burden of chemotherapy in multiple myeloma in Japan: a time trade-off valuation studyTadao Ishida, Mayuko Nakakoji, Tatsunori Murata, et al.
Cancer Medicine|September 15, 2025
Cost-Effectiveness Analysis of First-Line Chemotherapy for Metastatic Pancreatic Cancer in JapanYuriko Sasahara, Yuki Takumoto, Tatsunori Murata, et al.
Patient Preference and Adherence|July 19, 2023
Preferences for Rehabilitation in Persons with a History of Stroke: A Discrete Choice ExperimentShinichi Noto, Tatsunori Murata, Shota Saito, et al.
Health and Quality of Life Outcomes|February 10, 2024
Comparison of four value sets derived using different TTO and DCE approaches: application to the new region-specific PBM, AP-7DTakeru Shiroiwa, Tatsunori Murata, Yasuhiro Morii, et al.
SAGE Open Medicine|September 7, 2019
Treatment procedures and associated medical costs of methicillin-resistant <i>Staphylococcus aureus</i> infection in Japan: A retrospective analysis using a database of Japanese employment-based health insuranceAkira Yuasa, Tatsunori Murata, Keiji Imai, et al.
Health Economics Review|December 23, 2022
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in JapanYuki Takumoto, Yuriko Sasahara, Hiroto Narimatsu, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Health Economics and Outcomes Research|July 21, 2020
Relationship Between the Number of Occlusal Supporting and Medical Cost: Analysis Using Large Claims Database from Employee Health Care Insurance in JapanTatsunori Murata, Korenori Arai, Kosuke Kashiwagi, et al.
Value in Health Regional Issues|December 19, 2021
Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment With Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in JapanTomohiro Hirose, Isao Kawaguchi, Tatsunori Murata, et al.
Advances in Therapy|September 13, 2023
Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled TrialsSeiji Fukumoto, Tatsunori Murata, Yutaka Osuga, et al.
The Journal of Dermatology|March 4, 2017
Treatment patterns of postherpetic neuralgia patients before and after the launch of pregabalin and its effect on medical costs: Analysis of Japanese claims data provided by Japan Medical Data CenterMariko Honda, Tatsunori Murata, Nozomi Ebata, et al.
Journal of Medical Economics|April 3, 2023
Evaluating process utilities for the treatment burden of chemotherapy in multiple myeloma in Japan: a time trade-off valuation studyTadao Ishida, Mayuko Nakakoji, Tatsunori Murata, et al.
Cancer Medicine|September 15, 2025
Cost-Effectiveness Analysis of First-Line Chemotherapy for Metastatic Pancreatic Cancer in JapanYuriko Sasahara, Yuki Takumoto, Tatsunori Murata, et al.
Patient Preference and Adherence|July 19, 2023
Preferences for Rehabilitation in Persons with a History of Stroke: A Discrete Choice ExperimentShinichi Noto, Tatsunori Murata, Shota Saito, et al.
Health and Quality of Life Outcomes|February 10, 2024
Comparison of four value sets derived using different TTO and DCE approaches: application to the new region-specific PBM, AP-7DTakeru Shiroiwa, Tatsunori Murata, Yasuhiro Morii, et al.
SAGE Open Medicine|September 7, 2019
Treatment procedures and associated medical costs of methicillin-resistant <i>Staphylococcus aureus</i> infection in Japan: A retrospective analysis using a database of Japanese employment-based health insuranceAkira Yuasa, Tatsunori Murata, Keiji Imai, et al.
Health Economics Review|December 23, 2022
Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in JapanYuki Takumoto, Yuriko Sasahara, Hiroto Narimatsu, et al.
Pageof 5